News
AbbVie’s JUVMO Wins US FDA Approval for Parkinson’s Disease
A new treatment option for Parkinson’s Disease: AbbVie expects JUVMO to become available to patients in the US in October 2026.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
A new treatment option for Parkinson’s Disease: AbbVie expects JUVMO to become available to patients in the US in October 2026.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
